Orchestra BioMed Holdings Inc
Orchestra BioMed Holdings Inc (OBIO) Implied Volatility Current
OBIO implied volatility is 88%. IV Rank is 12%, placing current premiums in the bottom of their 52-week range.
Read more
Tracking OBIO implied volatility helps you identify when options premiums on Orchestra BioMed Holdings Inc are historically cheap or expensive, and where the best trades are hiding. Orchestra BioMed Holdings Inc implied volatility reflects the market's expectation of future price movement: when OBIO IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Orchestra BioMed Holdings Inc's implied volatility current levels in real time and filter for high-probability trades.
Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For OBIO, tracking metrics like OBIO IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on OBIO signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.
Orchestra BioMed Holdings, Inc. operates as a biomedical innovation company. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension; and Virtue Sirolimus AngioInfusion Balloon (SAB) for the treatment of atherosclerotic artery disease. Its products also comprise FreeHold retractors that are minimally invasive surgical device solutions. The company has a strategic collaboration with Medtronic for the development and commercialization of BackBeat CNT for the treatment of hypertension in pacemaker-indicated patients; and a strategic partnership with Terumo Corporation for the development and commercialization of Virtue SAB for the treatment of artery disease.
Orchestra BioMed Holdings, Inc. is based in New Hope, Pennsylvania.
Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where OBIO implied volatility sits today versus where it has been. Our scanner ranks Orchestra BioMed Holdings Inc implied volatility against its historical range, surfaces extremes in OBIO IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Orchestra BioMed Holdings Inc IV is rich or cheap — measure it, then act on it.
Implied Volatility
IV is compressed vs the past year - options are relatively cheap, favoring buyers.
As of September 25, 2026
Trade options with IV on your side
Track OBIO IV rank across every expiration, spot where volatility is elevated, and identify high-probability setups before the window closes.
Start your 14-day free trial→